Tag Samer A. Srour

Allogeneic Cell Transplantation for Myeloproliferative Neoplasms

Introduction Myeloproliferative neoplasms (MPN) are a heterogeneous group of myeloid stem cell disorders shared by certain clinical and biological similarities, and characterized by clonal myeloproliferation without significant dyserythropoiesis, granulocytic dysplasia, or monocytosis. Primary myelofibrosis (PMF), polycythemia vera (PV), and essential…

Patient and Donor Assessments in Preparation for Transplant

Introduction Hematopoietic cell transplantation (HCT) remains an essential therapeutic intervention for several high-risk hematologic neoplasms. HCT leads to durable responses and remissions for plasma cell neoplasms and indolent lymphomas and can be curative for aggressive lymphomas, acute leukemias, myelodysplastic syndromes,…